eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » BioMarin Pharmaceutical Inc. - Comment

BioMarin Pharmaceutical Inc. - Comment

Document ID: FDA-2009-D-0573-0011
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: February 01 2010, at 05:03 PM Eastern Standard Time
Date Posted: February 2 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: December 17 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: February 1 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80a89333
View Document:  View as format xml

View Comment

Please see attached comment.

Attachments:

BioMarin Pharmaceutical Inc. - Comment

Title:
BioMarin Pharmaceutical Inc. - Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 8
Eisai Inc. - Comment
Public Submission    Posted: 02/01/2010     ID: FDA-2009-D-0573-0005

Feb 01,2010 11:59 PM ET
Amgen, Inc. - Comment
Public Submission    Posted: 02/01/2010     ID: FDA-2009-D-0573-0007

Feb 01,2010 11:59 PM ET
sanofi-aventis - Comment
Public Submission    Posted: 02/01/2010     ID: FDA-2009-D-0573-0008

Feb 01,2010 11:59 PM ET
BioMarin Pharmaceutical Inc. - Comment
Public Submission    Posted: 02/02/2010     ID: FDA-2009-D-0573-0011

Feb 01,2010 11:59 PM ET
Lauren Elizabeth Black - Comment
Public Submission    Posted: 02/02/2010     ID: FDA-2009-D-0573-0012

Feb 01,2010 11:59 PM ET